## Abstract Pregnant Wistar rats were orally treated with the adenosine receptor agonist R‐phenylisopropyladenosine (R‐PIA) throughout the gestational period, and the status of the metabotropic glutamate (mGlu) receptor/phospholipase C transduction pathway from maternal and fetal brain was analyzed
Traumatic brain injury: Developmental differences in glutamate receptor response and the impact on treatment
✍ Scribed by Lea, Paul M. ;Faden, Alan I.
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 195 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1080-4013
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Perinatal brain injury following trauma, hypoxia, and/or ischemia represents a substantial cause of pediatric disabilities including mental retardation. Such injuries lead to neuronal cell death through either necrosis or apoptosis. Numerous in vivo and in vitro studies implicate ionotropic (iGluRs) and metabotropic (mGluRs) glutamate receptors in the modulation of such cell death. Expression of glutamate receptors changes as a function of developmental age, with substantial implications for understanding mechanisms of post‐injury cell death and its potential treatment. Recent findings suggest that the developing brain is more susceptible to apoptosis after injury and that such caspase mediated cell death may be exacerbated by treatment with N‐methyl‐D‐aspartate receptor antagonists. Moreover, group I metabotropic glutamate receptors appear to have opposite effects on necrotic and apoptotic cell death. Understanding the relative roles of glutamate receptors in post‐traumatic or post‐ischemic cell death as a function of developmental age may lead to novel targeted approaches to the treatment of pediatric brain injury. MRDD Research Reviews 2001;7:235–248. © 2001 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES